MicroPort Surgical

MicroPort Surgical is a MicroPort-affiliated medical device company focused on surgical and critical care solutions rather than therapeutics. Its business centers on products used in cardiac surgery and extracorporeal circulation, including oxygenators, cannulae, tubing and related consumables, and it has expanded into extracorporeal life support through the Hemovent acquisition. The company also references occluder products for structural heart disease intervention and broader ambitions in artificial heart, extracorporeal carbon dioxide removal, and intelligent decision-support applications. MicroPort Surgical appears to operate as a private subsidiary within the broader MicroPort ecosystem, with activities spanning China and Europe. For a healthcare analyst, it is best characterized as a commercial-stage medtech business focused on perfusion, ECMO/ECLS, and cardiac/critical care procedure support.